Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Total Debt (2016)

Gyre Therapeutics (GYRE) has disclosed Total Debt for 7 consecutive years, with $28000.0 as the latest value for Q3 2016.

  • Quarterly Total Debt fell 95.86% to $28000.0 in Q3 2016 from the year-ago period, while the trailing twelve-month figure was $28000.0 through Sep 2016, down 95.86% year-over-year, with the annual reading at $1.2 million for FY2015, N/A changed from the prior year.
  • Total Debt for Q3 2016 was $28000.0 at Gyre Therapeutics, down from $130000.0 in the prior quarter.
  • The five-year high for Total Debt was $2.7 million in Q1 2012, with the low at $28000.0 in Q3 2016.
  • Average Total Debt over 5 years is $1.2 million, with a median of $1.2 million recorded in 2015.
  • The sharpest move saw Total Debt surged 41.42% in 2015, then plummeted 95.86% in 2016.
  • Over 5 years, Total Debt stood at $2.0 million in 2012, then plummeted by 32.01% to $1.4 million in 2013, then tumbled by 64.62% to $478000.0 in 2014, then surged by 141.84% to $1.2 million in 2015, then tumbled by 97.58% to $28000.0 in 2016.
  • According to Business Quant data, Total Debt over the past three periods came in at $28000.0, $130000.0, and $196000.0 for Q3 2016, Q2 2016, and Q1 2016 respectively.